Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors

Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets...

Full description

Bibliographic Details
Main Authors: Armin Sami, Michael E. Selzer, Shuxin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Cellular Neuroscience
Subjects:
LAR
Online Access:https://www.frontiersin.org/article/10.3389/fncel.2020.00174/full
id doaj-1994916447cf4d11b80f8de760e64977
record_format Article
spelling doaj-1994916447cf4d11b80f8de760e649772020-11-25T03:36:23ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022020-07-011410.3389/fncel.2020.00174546519Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth InhibitorsArmin Sami0Armin Sami1Michael E. Selzer2Michael E. Selzer3Shuxin Li4Shuxin Li5Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesDepartment of Anatomy and Cell Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesShriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesDepartment of Neurology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesShriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesDepartment of Anatomy and Cell Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United StatesAxon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.https://www.frontiersin.org/article/10.3389/fncel.2020.00174/fullscar inhibitionCSPG receptorLARPTPσaxon regenerationintracellular signaling
collection DOAJ
language English
format Article
sources DOAJ
author Armin Sami
Armin Sami
Michael E. Selzer
Michael E. Selzer
Shuxin Li
Shuxin Li
spellingShingle Armin Sami
Armin Sami
Michael E. Selzer
Michael E. Selzer
Shuxin Li
Shuxin Li
Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
Frontiers in Cellular Neuroscience
scar inhibition
CSPG receptor
LAR
PTPσ
axon regeneration
intracellular signaling
author_facet Armin Sami
Armin Sami
Michael E. Selzer
Michael E. Selzer
Shuxin Li
Shuxin Li
author_sort Armin Sami
title Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
title_short Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
title_full Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
title_fullStr Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
title_full_unstemmed Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
title_sort advances in the signaling pathways downstream of glial-scar axon growth inhibitors
publisher Frontiers Media S.A.
series Frontiers in Cellular Neuroscience
issn 1662-5102
publishDate 2020-07-01
description Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.
topic scar inhibition
CSPG receptor
LAR
PTPσ
axon regeneration
intracellular signaling
url https://www.frontiersin.org/article/10.3389/fncel.2020.00174/full
work_keys_str_mv AT arminsami advancesinthesignalingpathwaysdownstreamofglialscaraxongrowthinhibitors
AT arminsami advancesinthesignalingpathwaysdownstreamofglialscaraxongrowthinhibitors
AT michaeleselzer advancesinthesignalingpathwaysdownstreamofglialscaraxongrowthinhibitors
AT michaeleselzer advancesinthesignalingpathwaysdownstreamofglialscaraxongrowthinhibitors
AT shuxinli advancesinthesignalingpathwaysdownstreamofglialscaraxongrowthinhibitors
AT shuxinli advancesinthesignalingpathwaysdownstreamofglialscaraxongrowthinhibitors
_version_ 1724550235220344832